Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


The Effect of Brief Potent Glutamatergic Modulation on Disordered Alcohol Use


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02539511

Organisation Name: New York State Psychiatric Institute

Overal Status: Completed

Start Date: July 2015

Last Update: February 11, 2020

Lead Sponsor: New York State Psychiatric Institute

Brief Summary: Alcohol use disorders remain a significant public health problem. The pharmacological facilitation of behavioral treatment represents a promising strategy for addressing disordered drinking. Alcohol use disorders are recognized to be associated with various vulnerabilities that complicate the course of treatment and that may be amenable to glutamate modulators. The purpose of this randomized, double-blind, controlled trial is to test various glutamate modulators in conjunction with motivational enhancement therapy (MET) for alcohol use disorders.

Conditions:
  • Alcohol Dependence


Total execution time in seconds: 0.16736483573914